Sonovum GmbH

Introducing our member:

Sonovum develops innovative medical devices for non-invasive brain monitoring. The UltraEASY 3, CE-marked under MDD Class IIa, enables ultrasound-based detection* of the cerebral pulse waveform. This biosignal is used in various fields of research to classify and monitor neurological conditions.

The successor to the UltraEASY 3L^, TTUS in^TBI®, is currently undergoing clinical trials^. As the first medical device for the noninvasive measurement of intracranial pressure, it is expected to be available in 2025.
^{*Transcranial Transmission Ultrasound, TTUS®}